Response to treatment, relapse and outcome of two dogs treated for Mycobacterium avium infection

J Small Anim Pract. 2024 Nov;65(11):838-844. doi: 10.1111/jsap.13788. Epub 2024 Oct 6.

Abstract

A 3-year-old male neutered Golden Retriever with nasal swelling and lymphadenopathy was diagnosed with diffuse Mycobacterium avium infection. Treatment with 9 months of enrofloxacin, clarithromycin and rifampicin was successful, but relapsed 10 months later with lymphadenopathy, skin plaques and testicular involvement. Repeat treatment for 12 months was effective but 15 months later a second relapse responded to the same therapy which is ongoing with survival from diagnosis of 82 months. A 1-year-old male neutered Portuguese Podengo was diagnosed with polyarthritis and M. avium infection and treated with enrofloxacin, clarithromycin and rifampicin for 4 months but relapsed, subsequently responding to combined pradofloxacin, rifampicin, doxycycline and ethambutol. After 12 months of treatment, M. avium was detected and treatment extended to 17 months before stopping when no organism was detected. Relapse occurred after 6 weeks, responding to retreatment but relapsing (polyarthropathy, lymphadenomegaly) after 15 months, with euthanasia 38 months after diagnosis. Dogs with M. avium are challenging to treat with frequent relapse; however, long-term survival is possible.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Clarithromycin / therapeutic use
  • Dog Diseases* / drug therapy
  • Dog Diseases* / microbiology
  • Dogs
  • Drug Therapy, Combination
  • Enrofloxacin / therapeutic use
  • Ethambutol / therapeutic use
  • Fluoroquinolones / therapeutic use
  • Male
  • Mycobacterium avium* / drug effects
  • Recurrence*
  • Rifampin / therapeutic use
  • Treatment Outcome
  • Tuberculosis / drug therapy
  • Tuberculosis / veterinary

Substances

  • Anti-Bacterial Agents
  • Clarithromycin
  • Rifampin
  • Fluoroquinolones
  • Enrofloxacin
  • Ethambutol